Active ingredientOrciprenaline SulfateCat. No. P-O028-001CAS 5874-97-5Family · Pharmaceutical analytical standards
Orciprenaline
A beta-2 receptor agonist bronchodilator, also known as metaproterenol, discovered in 1961 as a longer-acting alternative to isoprenaline and used for asthma by mouth and by aerosol. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It is the resorcinol version of isoprenaline: with one hydroxyl group moved on the ring it escapes the lungs' COMT enzyme, which is why it acts for longer.
Go to the active ingredient →Active ingredientOrciprenaline SulfateCat. No. P-O028-001CAS 5874-97-5
Pharmacopoeial impurityOrciprenaline EP Impurity ACat. No. P-O028-002CAS 70988-89-5
Pharmacopoeial impurityOrciprenaline EP Impurity CCat. No. P-O028-003No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceOrciprenaline sulfate CRSEDQM code O0180000Family OrciprenalineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.